Q32 Bio Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.36

+0.46 (+7.80%)

As of Mar 31, 3:50 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +339.3% upside

Low Target $24.18

Average Target $27.94

High Target $39.76

Current Price $6.36

Current
$6.36

Target
$27.94

$24.18 $27.94 avg $39.76

Scenario Analysis

Bear Case

$24.18

280.2%

Low target

Base Case

$27.94

+339.3%

Avg target

Bull Case

$39.76

+525.2%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$7.85

-19.0% from high

52-Week Low

$1.35

+372.9% from low

Target vs 52W High

$27.94

+255.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%